Search research articles
Contact Us
Filters
Showing results (141-150 of 198) with videos related to
Page
of 20
Sort By:
Bone Marrow Transplantation
|
September 1, 1993
Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies
L Catani, L Gugliotta, M Mattioli Belmonte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2003
Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study
C Dazzi, A Cariello, P Giovanis, et al.
British Journal of Haematology
|
August 6, 2000
Second chronic phase before transplantation is crucial for improving survival of blastic phase chronic myeloid leukaemia
G Visani, G Rosti, G Bandini, et al.
Cancer Genetics and Cytogenetics
|
July 1, 1983
Normal bone marrow karyotype in paroxysmal nocturnal hemoglobinuria--a cooperative European study
A Zaccaria, D Barbieri, G L Castoldi, et al.
Haematologica
|
August 24, 1999
A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia
G Meloni, D Russo, M Baccarani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2001
High-dose chemotherapy for ovarian carcinoma: long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)
J A Ledermann, R Herd, D Maraninchi, et al.
Anticancer Research
|
July 1, 1996
Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo)
I Buggia, M Zecca, E P Alessandrino, et al.
Bone Marrow Transplantation
|
June 30, 1998
Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phase
A Bonini, G Bandini, G Rosti, et al.
Bone Marrow Transplantation
|
July 1, 1996
Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantation
F Lauria, D Raspadori, M A Ventura, et al.
Bone Marrow Transplantation
|
May 24, 2005
High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)
C Bengala, V Guarneri, J Ledermann, et al.
Page
of 20
Search research articles
Search
Showing results (141-150 of 198) with videos related to
Sort By:
Page
of 20
Bone Marrow Transplantation
|
September 1, 1993
Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies
L Catani, L Gugliotta, M Mattioli Belmonte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2003
Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study
C Dazzi, A Cariello, P Giovanis, et al.
British Journal of Haematology
|
August 6, 2000
Second chronic phase before transplantation is crucial for improving survival of blastic phase chronic myeloid leukaemia
G Visani, G Rosti, G Bandini, et al.
Cancer Genetics and Cytogenetics
|
July 1, 1983
Normal bone marrow karyotype in paroxysmal nocturnal hemoglobinuria--a cooperative European study
A Zaccaria, D Barbieri, G L Castoldi, et al.
Haematologica
|
August 24, 1999
A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia
G Meloni, D Russo, M Baccarani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2001
High-dose chemotherapy for ovarian carcinoma: long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)
J A Ledermann, R Herd, D Maraninchi, et al.
Anticancer Research
|
July 1, 1996
Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo)
I Buggia, M Zecca, E P Alessandrino, et al.
Bone Marrow Transplantation
|
June 30, 1998
Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phase
A Bonini, G Bandini, G Rosti, et al.
Bone Marrow Transplantation
|
July 1, 1996
Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantation
F Lauria, D Raspadori, M A Ventura, et al.
Bone Marrow Transplantation
|
May 24, 2005
High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)
C Bengala, V Guarneri, J Ledermann, et al.
Page
of 20